Expression of heme oxygenase-1 by endothelial cells: a protective response to injury in transplantation

Bibliography

• CINES DB, POLLAK ES, BUCK CA et al.: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 91(103527–3561.
   Google Scholar
• ••Extensive and comprehensive review on endothelial cellbiology.
   Google Scholar
• SAMMUT IA, FORESTI R, CLARK JE et al.: Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br. J. Pharmacol. (1998) 125(7):1437–1444.
   PubMed Web of Science ®Google Scholar
• DE CATERINA R, LIBBY P, PENG HB et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expres-sion of adhesion molecules and proinflammatory cytokines. j Clin. Invest. (1995) 96(0:60–68.
   Google Scholar
• WALSH K, SATA M: Negative regulation of inflammation by Fas ligand expression on the vascular endothelium. Trends Cardiovasc. Med. (1999) 9(1-2):34–41.
   PubMed Web of Science ®Google Scholar
• ••Highlights a new mechanism by which resting endothelialcells prevent physical interaction with circulating leukocytes.
   Google Scholar
• TEDESCO F, PAUSA M, NARDON E, INTRONA M, MANTOVANI A, DOBRINA A: The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. (1 9 9 7) 185(9)1619–1627.
   PubMedGoogle Scholar
• SAADI S, PLATT JL: Transient perturbation of endothe-lial integrity induced by natural antibodies and complement. J. Exp. Med. (1995) 181(0:21–31.
   PubMedGoogle Scholar
• ••Original description that endothelial cells can undergotransient retraction when exposed to a pro-inflammatory stimulus. Transient retraction of activated endothelial cell in this manner could lead to exposure of the pro-coagulant sub-endothelium and thus to thrombosis.
   Google Scholar
• SAADI S, HOLZKNECHT RA, PATTE CP, STERN DM, PLATT JL: Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. (1 99 5) 182(6):1807–1814.
   PubMed Web of Science ®Google Scholar
• MANTOVANI A, BUSSOLINO F, INTRONA M: Cytokine regulation of endothelial cell function-from molecular level to the bedside. Immunol. Today (1997) 18(5):231–240.
   PubMedGoogle Scholar
• ••Extensive and comprehensive review that focuses on theresponse of endothelial cells to pro-inflammatory stimuli.
   Google Scholar
• GIMBRONE MJ, BEVILACQUA MP, CYBULSKY MI: Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann. NY Acad. Sci. (1990) 598(77):77–85.
   PubMedGoogle Scholar
• BACH FH, HANCOCK WW, FERRAN C: Protective genes expressed in endothelial cells-a regulatory response to injury. Immunol Today (1997) 18(10):483–486.
   PubMedGoogle Scholar
• ••Original proposal that expression of anti-inflammatorygenes associated with endothelial cell activation may be part of a physiological response that limits the pro-inflammatory phenotype of activated endothelial cells and prevents endothelial cell apoptosis.
   Google Scholar
• BACH FH, ROBSON SC, FERRAN C et al.: Endothelial cell activation and thromboregulation during xenograft rejection. Immunolog. Rev. (1994) 141(5):5–30.
   PubMedGoogle Scholar
• PLATT JL, VERCELLOTTI GM, LINDMAN BJ, OEGEMA TR, JR., BACH FH, DALMASSO AP: Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J. Exp. Med. (1 99 0) 171(4)1363–1368.
   PubMedGoogle Scholar
• •Original description that endothelial cells can lose antico-agulant heparan sulphate when exposed to a pro-inflammatory stimulus. This phenomenon may contribute in a significant manner to the acquisition of a pro-coagulant phenotype associated with endothelial cell activation.
   Google Scholar
• SCARPATI EM, SADLER JE: Regulation of endothelial cellcoagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombo-modulin by phorbol 12-myristate 13-acetate and tumour necrosis factor. J. Biol. Chem. (1989) 264(34):20705–20713.
   PubMed Web of Science ®Google Scholar
• ROBSON SC, KACZMAREK E, SIEGEL JB et al.: Loss of ATPdiphosphohydrolase activity with endothelial cell activation. J. Exp. Med. (1997) 185(0:153–163.
   PubMedGoogle Scholar
• •Original description that endothelial cells can lose anti-thrombotic CD39 when exposed to a pro-inflammatory stimulus. This phenomenon may contribute in a significant manner to the acquisition of a pro-thrombotic phenotype associated with endothelial cell activation.
   Google Scholar
• WRIGHTON CJ, HOFER WR, MOLL T, EYTNER R, BACH FH: Inhibition of endothelial cell activation by adenovirus-mediated expression of IxBcc, an inhibitor of the transcription factor NF-xB. J. Exp. Med. (1996) 183 (3) :1013–1022.
   PubMed Web of Science ®Google Scholar
• ••Direct demonstration that the transcription factor NF-KBplays a pivotal in the upregulation of most of the pro-inflammatory genes that are expressed during endothe-lial cell activation.
   Google Scholar
• ANRATHER J, CSIZMADIA V, BROSTJAN C, SOARES MP, BACH FH, WINKLER H: Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-KB. J. Clin. Invest. (1997) 99 (4):763–772.
   PubMed Web of Science ®Google Scholar
• •Description of a dominant negative mutant of the transcrip-tion factor p65/Re1A (p65RHD) that suppresses the expres-sion of most NF-KB dependent pro-inflammatory genes associated with endothelial cell activation. In addition, this article demonstrates that it is possible to express this dominant negative mutant in primary endothelial cells under the regulation of a tetracyclin responsive promoter.
   Google Scholar
• SOARES MP, MUNIAPPAN A, KACZMAREK E et al.: Adenovirus mediated expression of a dominant negative mutant of p65/Re1A Inhibits proinflamma-tory gene expression in endothelial cells without sensitizing to apoptosis. J. Immunol. (1 9 9 8) 161:4572-4582.
   Google Scholar
• •Describes a dominant negative mutant of p65/RelA (p65RHD) that blocks the activation of the transcription factor NF-KB but does not sensitise endothelial cells to undergo apoptosis. In addition, this article highlights the role of c-myc in the regulation of endothelial cell apoptosis.
   Google Scholar
• COLLINS T, READ MA, NEISH AS, WHITLEY MZ, THANOSD, MANIATIS T: Transcriptional regulation of endothe-lial cell adhesion molecules: NF-03 and cytokine-inducible enhancers. FASEBJ (1995) 9(10):899–909.
   PubMed Web of Science ®Google Scholar
• OPIPARI AJ, BOGUSKI MS, DIXIT VM: The A20 cDNA induced by tumour necrosis factor alpha encodes a novel type of zinc finger protein. J. Biol. Chem. (1990) 265(25)14705–14708.
   PubMed Web of Science ®Google Scholar
• KARSAN A, YEE E, KAUSHANSKY K, HARLAN JM: Cloningof human Bc1-2 homologue: inflammatory cytokines induce human Al in cultured endothelial cells. Blood (1996) 87(8)3089–3096.
   PubMedGoogle Scholar
• STROKA DM, BADRICHANI AZ, BACH FH, FERRAN C: Overexpression of Al, an NE-KB-inducible anti-apoptotic bc1 gene, inhibits endothelial cell activation. Blood (1999) 93 (11) 3803–3810.
   PubMed Web of Science ®Google Scholar
• STEHLIK C, DE MARTIN R, KUMABASHIRI I, SCHMID JA, BINDER BR, LIPP J: Nuclear factor (NO-KB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumour necrosis factor alpha-induced apoptosis. J. Exp. Med. (1998) 188(1):211–216.
   PubMed Web of Science ®Google Scholar
• DEVERAUX QL, REED JC: IAP family proteins-suppressors of apoptosis. Genes Dev. (1 9 99) 13(3)239–252.
   PubMedGoogle Scholar
• MANNA SK, ZHANG HJ, YAN T, OBERLEY LW, AGGARWAL BB: Overexpression of manganese superoxide dismutase suppresses tumour necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. (1998) 273(20:13245–13254.
   PubMedGoogle Scholar
• DIMMELER S, HAENDELER J, NEHLS M, ZEIHER AM: Suppression of apoptosis by nitric oxide via inhibi-tion of interleukin-lbeta-converting enzyme (ICE)-like and cysteine protease protein (CPI)-32-like proteases. J. Exp. Med. (1997) 185(4):601–607.
   PubMed Web of Science ®Google Scholar
• WU MX, AO Z, PRASAD KV, WU R, SCHLOSSMAN SF: IEX-1L, an apoptosis inhibitor involved in NE-KB-mediated cell survival. Science (1 99 8) 281 (5379):998–1001.
   Google Scholar
• BADRICHANI AZ, STROKA DM, BILBAO G, CURIEL DT, BACH FH, FERRAN C: Bc1-2 and Bc1-XL serve an anti-inflammatory function in endothelial cells through inhibition of NE-kappaB. J. Clin. Invest. (1999) 103(4):543–553.
   PubMed Web of Science ®Google Scholar
• FERRAN C, STROKA DM, BADRICHANI AZ et al. A20 inhibits NE-KB activation in endothelial cells without sensitizing to tumour necrosis factor-mediated apoptosis. Blood (1998) 91(7)2249–2258.
   PubMed Web of Science ®Google Scholar
• ANRATHER J, CSIZMADIA V, SOARES MP, WINKLER H: Regulation of NE-KB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase C in primary endothelial cells. J. Biol. Chem. (1999) 274 (19) :13594–13603.
   PubMed Web of Science ®Google Scholar
• ••Original report that activation of the transcription factorp65/Re1A requires its phosphorylation in the N-terminal region. The authors demonstrate that phosphorylation of p65/Re1A requires the activation PKC and p21 ras. These data highlights a new mechanism that regulates NF-KB activation in endothelial cells.
   Google Scholar
• VANANTVVERP DJ, MARTIN SJ, KAFRI T, GREEN DR, VERMA IM: Suppression of TNF-a-induced apoptosis by NE-KB. Science (1996) 274(5288):787–789.
   PubMed Web of Science ®Google Scholar
• ••Three articles that demonstrate that activation of thetranscription factor NF-KB is required to protect cells from TNF-a-mediated apoptosis.
   Google Scholar
• WANG CY, MAYO MW, BALDWIN AS: TNF-and cancer therapy-induced apoptosis-potentiation by inhibi-tion of NE-KB. Science (1996) 274(5288):784–787.
   PubMed Web of Science ®Google Scholar
• ••See reference 30.
   Google Scholar
• BEG AA, BALTIMORE D: An essential role for NE-KB in preventing TNF-a-induced cell death. Science (1996) 274(5288)782–784.
   PubMedGoogle Scholar
• ••See reference 30.
   Google Scholar
• HAIMOVITZ FA, CORDON-CARDO C, BAYOUMY S et al.: Lipopolysaccharide induces disseminated endothelial cell apoptosis requiring ceramide. J. Exp. Med. (1997) 186(10:1831–1841.
   PubMedGoogle Scholar
• BACH FH, FERRAN C, SOARES M et al.: Modification of vascular responses in xenotransplantation: inflam-mation and apoptosis. Nature Med. (1997) 3(9):944–948.
   PubMed Web of Science ®Google Scholar
• BOMBELI T, KARSAN A, TAIT JF, HARLAN JM: Apoptotic vascular endothelial cells become procoagulant. Blood (1997) 89(7):2429–2442.
   PubMed Web of Science ®Google Scholar
• KORB LC, AHEARN JM: Clq binds directly and specifi-cally to surface blebs of apoptotic human keratino-cytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. (1 9 9 7) 158(104525–8.
   Google Scholar
• BOMBELI T, SCHWARTZ BR, HARLAN JM: Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood (1999) 93 (11):3831–3838.
   PubMed Web of Science ®Google Scholar
• OPIPARI AJ, HU HM, YABKOWITZ R, DIXIT VM: The A20zinc finger protein protects cells from tumour necrosis factor cytotoxicity. J. Biol. Chem. (1992) 267(18)12424–12427.
   PubMed Web of Science ®Google Scholar
• KARSAN A, YEE E, HARLAN JM: Endothelial cell deathinduced by tumour necrosis factor-alpha is inhibited by the Bc1-2 family member, Al. J. Biol. Chem. (1996) 271(44)27201–27204.
   PubMed Web of Science ®Google Scholar
• WONG GH, ELWELL JH, OBERLEY LW, GOEDDEL DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumour necrosis factor. Cell (1989) 58(5):923–931.
   PubMed Web of Science ®Google Scholar
• CHOI AM, ALAM J: Heme oxygenase-1: function, regula-tion, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Resp. Cell Mol. Biol. (1996) 15(0:9–19.
   PubMedGoogle Scholar
• ••(With reference 44) Two extensive and comprehensivereviews on the biological significance of the stress respon-sive gene, HO–1.
   Google Scholar
• MAINES MD: The heme oxygenase system: a regulator of second messenger gases. Ann. Rev. Pharmacol. Toxicol. (1997) 37(517):517–554.
   PubMedGoogle Scholar
• MCCOUBREY WK, JR., HUANG TJ, MAINES MD: Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. (1997) 247(2):725–732.
   PubMedGoogle Scholar
• WILLIS D: Overview of I10-1 in inflammatory patholo-gies. In: Inducible Enzymes in the Inflammatory Response. Willoughby DA, Tomlinson A (Eds.), Birkhauser, Basel, USA (1999):55–96.
   Google Scholar
• ••(With reference 41) Two extensive and comprehensivereviews on the biological significance of the stress respon-sive gene, HO–1.
   Google Scholar
• MAINES MD, A. K: The induction of heme oxidation invarious tissues by trace met als: evidence for the catabolism of endogenous heme by hepatic heme oxygenase. Ann. Clin. Res. (1976) 8 (Suppl. 17):39–46.
   PubMedGoogle Scholar
• KUTTY RK, DANIEL RF, RYAN DE, LEVIN W, MAINES MD:Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase. Arch. Biochem. Biophys. (1988) 260(2)638–644.
   PubMed Web of Science ®Google Scholar
• ALAM J, STEWART D, TOUCHARD C, BOINAPALLY S, CHOI AM, COOK JL: Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. (1999) 274(37):26071–26078.
   PubMed Web of Science ®Google Scholar
• ••Description of a new mechanism regulating the expressionof HO-1.
   Google Scholar
• BALLA J, JACOB HS, BALLA G, NATH K, EATON JW, VERCELLOTTI GM: Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensi-tization to oxidant damage. Proc. Nati Acad. Sci. USA (1993) 90(20)9285–9289.
   PubMed Web of Science ®Google Scholar
• ••Original report (with reference 49) that HO-1 has potentcytoprotective effects that protect endothelial cells from oxidative injury. The authors demonstrate that this protec-tive effect is dependent on the expression of ferritin.
   Google Scholar
• BALLA G, JACOB HS, BALLA J et al: Ferritin: a cytoprotec-tive anti-oxidant strategem of endothelium. J. Biol. Chem. (1992) 267(25):18148–18153.
   PubMed Web of Science ®Google Scholar
• ••Original report (with reference 48) that HO-1 has potentcytoprotective effects that protect endothelial cells from oxidative injury. The authors demonstrate that this protec-tive effect is dependent on the expression of ferritin.
   Google Scholar
• ESKEW JD, VANACORE RM, SUNG L, MORALES PJ, SMITHA: Cellular protection mechanisms against extracel-lular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. J. Biol. Chem. (1999) 274(2):638–648.
   PubMed Web of Science ®Google Scholar
• HARRISON PM, AROSIO P: Ferritins-molecular proper-ties, iron storage function and cellular regulation. Biochim. Biophys. Acta-Bioenergetics (1 9 9 6) 1275 (3):161–203.
   Google Scholar
• ••Encyclopaedic review on the biological function of ferritins.
   Google Scholar
• ALAM J, CAMHI S, CHOI AM: Identification of a secondregion upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J. Biol. Chem. (19 9 5) 2 70 (20) :11977–11984.
   Google Scholar
• TERRY CM, CLIKEMAN JA, HOIDAL JR, CALLAHAN KS: Effect of tumour necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am. J. Physiol. (1998) 274(3/Part 2):H883–891.
   Google Scholar
• TERRY CM, CLIKEMAN JA, HOIDAL JR, CALLAHAN KS: TNF-alpha and IL-lalpha induce heme oxygenase-1 via protein kinase C, Ca2±, and phospholipase A2 in endothelial cells. Am. J. Physiol. (1999) 2 76(5/Part 2):H1493–1501.
   Google Scholar
• HANCOCK WW, BUELOW R, SAYEGH MH, TURKA LA: Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nature Med. (1 9 9 8) 4(i2):1392-1396.
   Google Scholar
• ••Original observation that upregulation of HO-1 preventschronic rejection of cardiac allograft.
   Google Scholar
• MOTTERLINI R, FORESTI R, INTAGLIETTA M, WINSLOW RM: NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol. (1996) 2 70(1/Part 2):H107–114.
   Google Scholar
• JUCKETT M, ZHENG YH, YUAN H et al.: Heme and the endothelium-effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. J. Biol. Chem. (1998) 273(36):23388–23397.
   PubMed Web of Science ®Google Scholar
• POSS KD, TONEGAWA S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Nail Acad. Sci. USA (1997) 94(2010925–10930.
   Google Scholar
• ••Original description and characterisation (with reference59) of HO-1 deficient mice.
   Google Scholar
• POSS KD, TONEGAWA S: Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Nall Acad. Sci. USA (1997) 94(2010919–10924.
   Google Scholar
• ••Original description and characterisation (with reference58) of HO-1 deficient mice.
   Google Scholar
• YET SF, PERRELLA MA, LAYNE MD et al.: Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J. Clin. Invest. (1999) 103(8):R23–29.
   Google Scholar
• YACHIE A, NIIDA Y, WADA T et al: Oxidative stresscauses enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. (1999) 103(0:129–135.
   PubMedGoogle Scholar
• OTTERBEIN L, CHIN BY, OTTERBEIN SL, LOWE VC, FESSLER HE, CHOI AM: Mechanism of hemoglobin-induced protection against endotoxemia in rats: a ferritin-independent pathway. Am. J. Physiol. (1997) 2 72(2/Part 1):L268–275.
   Google Scholar
• •First of this set of four articles which demonstrate that HO-1 acts as an anti-inflammatory and cytoprotective gene in vivo.
   Google Scholar
• OTTERBEIN LE, KOLLS JK, MANTELL LL, COOK JL, ALAM J, CHOI AM: Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. (1999) 103(7):i047–i054.
   Google Scholar
• •See reference 62.
   Google Scholar
• OTTERBEIN LE, LEE PJ, CHIN BY et al: Protective effects of heme oxygenase-1 in acute lung injury. Chest (1999) 116(1 Suppl.):61S–635.
   Google Scholar
• •See reference 62.
   Google Scholar
• WILLIS D, MOORE AR, FREDERICK R, WILLOUGHBY DA: Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Med. (1996) 2(0:87–90.
   PubMedGoogle Scholar
• ••See reference 62.
   Google Scholar
• AMERSI F, BUELOW R, KATO H et al.: Upregulation ofheme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. (1999) 104:1631–1639.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI T, TERAKADO M, HORIO F, AOKI K, TANAKA M, NAKAJIMA H: Role of bilirubin as an anti-oxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem. Biophys. Res. Comm. (1996) 223(1):129–135.
   PubMed Web of Science ®Google Scholar
• SOARES MP, UN Y, ANRATHER J et al.: Expression of heme oxygenase-1 (H0-1) can determine cardiac xenograft survival. Nature Med. (1998) 4:1073–1077.
   PubMed Web of Science ®Google Scholar
• ••Original report that expression of HO-1 is required toprevent the rejection of cardiac transplants. The article also describes for the first time that HO-1 can act as an anti-apoptotic gene that prevents endothelial cells from undergoing TNF-a mediated apoptosis.
   Google Scholar
• EISENSTEIN RS, GARCIA MD, PETTINGELL W, MUNRO HN:Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc. Nail Acad. Sci. USA (1991) 88(3):688–692.
   PubMed Web of Science ®Google Scholar
• PETRACHE I, ALAM J, CHOI AMK: Heme oxygenase 1(H0-1) inhibits tumour necrosis factor-a (TIsIF-0-induced apoptosis in L929 cells. Cold Spring Harbor Seminar, Apoptosis. Cold Spring Harbor, New York, USA, 1997: 214.
   Google Scholar
• FERRIS C, JAFFREY SR, SAWA A et al: Haem oxygenase-1prevents cell death by regulating cellular iron. Nature Cell Biol. (1999) 1:152–157.
   PubMed Web of Science ®Google Scholar
• •Description that HO-1 prevents apoptosis through the upregulation of a new iron pump that inhibits the accumula-tion of pro-oxidant iron. The authors suggest that other end products of HO-1 activity (bilirubin and carbon monoxide) are not involved in the anti-apoptotic function of this gene.
   Google Scholar
• STOCKER R, YAMAMOTO Y, MCDONAGH AF, GLAZER AN, AMES BN: Bilirubin is an anti-oxidant of possible physiological importance. Science (1987) 235 (4792):1043–1046.
   PubMed Web of Science ®Google Scholar
• FERRAN C, MILLAN MT, CSIZMADIA V et al.: Inhibition ofNF-KB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Comm. (1995) 214(0:212–223.
   PubMedGoogle Scholar
• CAI J, JONES DP: Superoxide in apoptosis. Mitochon-drial generation triggered by cytochrome c loss. J. Biol. Chem. (1998) 273(19):11401–11404.
   PubMed Web of Science ®Google Scholar
• KROEMER G, PETIT P, ZAMZAMI N, VAYSSIERE JL, MIGNOTTE B: The biochemistry of programmed cell death. FASEB (1995) 9(13):1277–1287.
   PubMed Web of Science ®Google Scholar
• NAKAGAMI T, TOYOMURA K, KINOSHITA T, MORISAWAS: A beneficial role of bile pigments as an endogenous tissue protector: anticomplement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta (1993) 1158 (2) :189–193.
   PubMedGoogle Scholar
• MORITA T, PERRELLA MA, LEE ME, KOUREMBANAS S: Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Nall Acad. Sci. USA (1995) 92(5):1475–1479.
   PubMed Web of Science ®Google Scholar
• YET SF, PELLACANI A, PATTERSON C et al.: Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J. Biol. Chem. (1997) 272(7):4295–430i.
   PubMed Web of Science ®Google Scholar
• MORITA T, KOUREMBANAS S: Endothelial cell expres-sion of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. (1995) 96(6):2676–2682.
   PubMed Web of Science ®Google Scholar
• MOTTERLINI R, GONZALES A, FORESTI R, CLARK JE, GREEN CJ, WINSLOW RM: Heme oxygenase-l-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ. Res. (1998) 83 (5):568–577.
   PubMed Web of Science ®Google Scholar
• PFEIFER A, KLATT P, MASSBERG S et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J (1998) 17(11) 3045–3051
   PubMed Web of Science ®Google Scholar
• SCHMIDT HH, LOHMANN SM, WALTER U: The nitric oxide and cGMP signal transduction system: regula-tion and mechanism of action. Biochim. Biophys. Acta (1993) 1178(2):153–175.
   PubMed Web of Science ®Google Scholar
• SIOW RC, SATO H, MANN GE: Heme oxygenase-carbonmonoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc. Res. (1999 41(2)385–394.
   PubMed Web of Science ®Google Scholar
• WAGNER CT, DURANTE W, CHRISTODOULIDES N, HELLUMS JD, SCHAFER Al. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J. Clin. Invest. (1997) 100(3):589–596.
   PubMed Web of Science ®Google Scholar
• ••Observation that upregulation of HO-1 inhibits the activa-tion of circulating platelets, presumably through the genera-tion of carbon monoxide.
   Google Scholar
• BRUNE B, ULLRICH V: Inhibition of platelet aggregationby carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol (1987) 32(4)497–504.
   PubMed Web of Science ®Google Scholar
• OTTERBEIN LE, MANTELL LL, CHOI AM: Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. (1999) 276(4/Part 1):L688–694.
   Google Scholar
• ••Original description that carbon monoxide, an end productof heme catabolism by HO-1, can act as an anti-inflammatory and cytoprotective gene in vivo.
   Google Scholar
• TILNEY NL, GUTTMANN RD: Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation (1997) 64(7):945–947.
   PubMed Web of Science ®Google Scholar
• KELLY KJ, WILLIAMS WW, JR., COLVIN RB et al.: Intercel-lular adhesion molecule-l-deficient mice are protected against ischemic renal injury. J. Clin. Invest. (1996) 97(4):i056–1063.
   Google Scholar
• TAKADA M, NADEAU KC, SHAW GD, MARQUETTE KA, TILNEY NU: The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibi-tion by a soluble P-selectin ligand. j Clin. Invest. (1997) 99(10:2682–2690.
   Google Scholar
• CURSIO R, GUGENHEIM J, RICCI JE et al.: A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J (1999) 13 (2):253–261.
   PubMed Web of Science ®Google Scholar
• YAOITA H, OGAWA K, MAEHARA K, MARUYAMA Y: Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation (1998) 97(3):276–281.
   PubMed Web of Science ®Google Scholar
• MAULIK N, SHARMA HS, DAS DK: Induction of the haemoxygenase gene expression during the reperfusion of ischemic rat myocardium. J. Mol Cell. Cardiol. (1996) 28(6) :1261–1270.
   PubMed Web of Science ®Google Scholar
• MAULIK N, ENGELMAN DT, WATANABE M, ENGELMANRM, DAS DK: Nitric oxide a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol. Biochem. (1996) 157(1-2):75–86.
   Google Scholar
• MAULIK N, ENGELMAN DT, WATANABE M et al.: Nitricoxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation (1996) 94(9 Suppl.):II398–406.
   Google Scholar
• DENNERY PA, MCDONAGH AF, SPITZ DR, RODGERS PA, STEVENSON DK: Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Rad. Biol. Med. (1995) 19(4)395–404.
   PubMed Web of Science ®Google Scholar
• HAYASHI S, TAKAMIYA R, YAMAGUCHI T et al.: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. (1999) 85:663–671.
   PubMed Web of Science ®Google Scholar
• GOULD DS, AUCHINCLOSS H, JR: Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today (1999) 20 (2) :77–82.
   PubMedGoogle Scholar
• MATZINGER P: Tolerance, danger, and the extended family. Ann. Rev. Immunol (1994) 12:991–1045.
   PubMed Web of Science ®Google Scholar
• ••The author proposes her theory that in order to achieveactivation of the immune system, antigens have to be recognised in a complex context that reveals that they are potentially dangerous.
   Google Scholar
• CLAYBERGER C, PARHAM P, ROTHBARD J, LUDWIG DS, SCHOOLNIK GK, KRENSKY AM: HLA-A2 peptides can regulate cytolysis by human allogeneic T lympho-cytes. Nature (1987) 330(6150) :763–765.
   PubMed Web of Science ®Google Scholar
• PARHAM P, CLAYBERGER C, ZORN SL, LUDWIG DS, SCHOOLNIK GK, KRENSKY AM: Inhibition of alloreac-tive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature (1 9 8 7) 325 (6105):625–658.
   Google Scholar
• IYER S, WOO J, CORNEJO MC et al.: Characterization and biological significance of immunosuppressive peptide D2702.75-84 (E-IV) binding protein-isolation of heme oxygenase-1. J. Biol. Chem. (1998) 2 73 (5):2692–2697.
   Google Scholar
• CUTURI MC, JOSEIN R, DOUILLARD P et al.: Prolongation of allogeneic heart graft survival in rats by administra-tion of peptide (a.a. 75-8') from the alphal helix of the firts domain of HLA-B7 01. Transplantation (1995) 59:661–669.
   PubMed Web of Science ®Google Scholar
• BUELOW R, VEYRON P, CLAYBERGER C, POULETTY P, TOURAINE JL: Prolongation of skin allograft survival in mice following administration of allotrap. Transplan-tation (1995) 59:455–460.
   PubMed Web of Science ®Google Scholar
• BROUARD S, CUTURI M, PIGNON P et al: Prolongation of heart xenograft survival in a hamster to Rat model following therapy with a rationally designed immuno-suppressive peptide. Transplantation (1999) 67:1614 :1631.
   Google Scholar
• GIRAL M, CUTURI MC, NGUYEN JM et al: Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA derived peptides. Transplantation (1996) 63:1004–1011.
   Web of Science ®Google Scholar
• MURPHY B, KIM K, BUELOW R, SAYEGH M, HANCOCK W: Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis/Fischer 344 model of chronic allograft rejection. Transplantation (1997) 64:14–19.
   PubMed Web of Science ®Google Scholar
• CUTURI M, F C, J W et al.: RDP1258 a new immunosup-pressive peptide rationnally designed prolongs allograft survival in rats: analysis of the mechanism of action. Mol. Med. (1999) [In press].
   PubMedGoogle Scholar
• WOO J, IER S, CORNEJO MC et al. Stress protein induced immunosuppression : inhibition of cellular immune effector functions following overexpression of heme oxygenase (HSP 32). Transpl. Immunol (1998) (In Press)
   PubMedGoogle Scholar
• AZUMA H, TILNEY NL: Chronic graft rejection. Curr. Opin. Immunol. (1994) 6(5):770–776.
   PubMed Web of Science ®Google Scholar
• RUSSELL PS, CHASE CM, WINN HJ, COLVIN RB: Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am. J. Pathol. (1994) 144 (2) 260–274.
   PubMed Web of Science ®Google Scholar
• RUSSELL ME, WALLACE AF, HANCOCK WW et al.: Upregu-lation of cytokines associated with macrophage activa-tion in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation (1995) 59(4):572–578.
   PubMed Web of Science ®Google Scholar
• SCHMID C, HEEMANN U, TILNEY NL: Factors contrib-uting to the development of chronic rejection in heterotopic rat heart transplantation. Transplantation (1997) 64(2):222–228.
   PubMed Web of Science ®Google Scholar
• TULLIUS SG, TILNEY NL: Both alloantigen-dependent and-independent factors influence chronic allograft rejection. Transplantation (1995) 59(3):313–318.
   PubMed Web of Science ®Google Scholar
• TULLIUS SG, NIEMINEN M, BECHSTEIN WO et al. Contri-bution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model. Kidney InL (1998) 5 3 (2) 465–472
   PubMed Web of Science ®Google Scholar
• ISHIKAWA K, NAVAB M, LEITINGER N, FOGELMAN AM, LUSIS AJ: Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. j Clin. Invest. (1997) 100 (5) :1209–1216.
   Google Scholar
• SHEARS LL, KAWAHARADA N, TZENG E et al.: Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J. Clin. Invest. (1997) 100(8) :2035–2042.
   PubMed Web of Science ®Google Scholar
• ••This article proposes that chronic rejection of immediatelyvascularised transplants may be linked to the observation that the expression of iNOS, and thus the generation of NO, is suppressed in the vessels of such grafts.
   Google Scholar
• HARTSFIELD CL, ALAM J, COOK JL, CHOI AM: Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am. J. Physiol. (1997) 273(5/Part 01980–1988.
   Google Scholar
• DURANTE W, KROLL MH, CHRISTODOULIDES N, PEYTON KJ, SCHAFER AT: Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. (1997) 80(4):557–564.
   PubMed Web of Science ®Google Scholar
• WHITLEY WD, HANCOCK WW, KUPIEC-WEGLINSKI JW, DESOUSA M, TILNEY NL: Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats. Transplantation (1993) 56(5):1182–1188.
   PubMed Web of Science ®Google Scholar
• LEE PJ, ALAM J, WIEGAND GW, CHOI AM: Overexpres-sion of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc. Natl Acad. ScL USA (1996) 93(19):10393–10398.
   PubMed Web of Science ®Google Scholar
• PLATT JL: New directions for organ transplantation. Nature (1998) 392(6679 Suppl.):11–17.
   PubMedGoogle Scholar
• •Extensive review in organ transplantation.
   Google Scholar
• BACH PH, ROBSON SC, WINKLER H et al.: Barriers to xenotransplantation. Nature Med. (1995) 1 (9):869–873.
   PubMed Web of Science ®Google Scholar
• SOARES MP, UN Y, SATO K et al.: Pathogenesis of and potential therapies for delayed xenograft rejection. Curr.Opin. Organ Transplant. (1999) 4:80–89.
   Google Scholar
• •Review of the mechanisms underlying the rejection of immediately vascularised organs transplanted across species.
   Google Scholar
• BACH PH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC: Delayed xenograft rejection. Immunol. Today (1996) 17(8):379–384.
   PubMedGoogle Scholar
• MIYATAKE T, SATO K, TAKIGAMI K et al.: Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J. Immunol. (1998) 160(8):4114–4123.
   PubMed Web of Science ®Google Scholar
• SATO K, TAKIGAMI K, MIYATAKE T et al. Suppression of delayed xenograft rejection by specific depletion of elicited antibodies of the IgM isotype. Transplantation (1999) 68(6):844–854.
   PubMed Web of Science ®Google Scholar
• VAN DEN BERG RH, FABER-KROL MC, SIM RB, DAHA MR: The first subcomponent of complement, Clq, triggers the production of IL-8, IL-6, and monocyte chemoat-tractant peptide-1 by human umbilical vein endothe-lial cells. J. Immunol. (1998) 161(12):6924–6930.
   PubMed Web of Science ®Google Scholar
• LOZADA C, LEVIN RI, HUIE M et al: Identification of Clq as the heat-labile serum co-factor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc. Natl Acad. ScL USA (1995) 92(18):8378–8382.
   PubMed Web of Science ®Google Scholar
• SOARES MP, LIN Y, SATO K, STUHLMEIER KM, BACH PH: Accommodation. Immunol. Today (1999) 20(10)434–437.
   PubMedGoogle Scholar
• ••The authosr propose and provide evidence that immedi-ately vascularised grafts can prevent their own rejection through the expression of protective genes. Particular emphasis is given to the role of HO-1 in this phenomenon.
   Google Scholar
• KOYAMADA N, MIYATAKE T, CANDINAS D et al.: Transient complement inhibition plus T-cell immuno-suppression induces long-term survival of mouse-to-rat cardiac xenografts. Transplantation (1998) 65 (9):1210–1215.
   PubMed Web of Science ®Google Scholar
• BACH PH, FERRAN C, HECHENLEITNER P et al.: Accommodation of vascularized xenografts: expres-sion of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nature Med. (1997) 3(2):196–204.
   PubMed Web of Science ®Google Scholar
• ••Original report that immediately vascularised grafts thatsurvive long-term under a given immunosuppressive regimen express a series of protective genes that may contribute to their survival.
   Google Scholar